Corvus Pharmaceuticals CRVS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's change in other assets?
- Corvus Pharmaceuticals (CRVS) reported change in other assets of -$88K in Q1 2026.
- How has Corvus Pharmaceuticals's change in other assets changed year-over-year?
- Corvus Pharmaceuticals's change in other assets decreased by 7.3% year-over-year, from -$82K to -$88K.
- What is the long-term trend for Corvus Pharmaceuticals's change in other assets?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's change in other assets has grown at a 17.4% compound annual growth rate (CAGR), from -$178K to -$338K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.